| P50 | author | Alison M Mondul | Q54269242 |
| | Stephanie J. Weinstein | Q88595407 |
| | Demetrius Albanes | Q28321446 |
| | Jarmo Virtamo | Q28360660 |
| P2860 | cites work | Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer | Q57559910 |
| | Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study | Q58813396 |
| | Inverse association between serum total cholesterol and cancer mortality in Dutch civil servants | Q72796019 |
| | Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer | Q79776038 |
| | Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort | Q81523607 |
| | Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials | Q21261910 |
| | Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse, and physical activity | Q23923014 |
| | Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial | Q33882778 |
| | The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review | Q33948322 |
| | High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism | Q34137900 |
| | Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort | Q34418735 |
| | Statins and prostate cancer risk: a case-control study | Q34433638 |
| | Serum retinol and the inverse relationship between serum cholesterol and cancer | Q34746126 |
| | The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay | Q34861374 |
| | Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer | Q36501079 |
| | Statin drugs and risk of advanced prostate cancer | Q36688183 |
| | Association between plasma cholesterol and prostate cancer in the PSA era. | Q36877126 |
| | Statin use and risk of prostate cancer: results from a population-based epidemiologic study | Q36978974 |
| | Do the cholesterol-lowering properties of statins affect cancer risk? | Q37115072 |
| | Serum cholesterol and risk of cancer in a cohort of 39,000 men and women | Q39648674 |
| | Cancer incidence in humans: relationship to plasma lipids and relative weight | Q43758912 |
| | Serum cholesterol and the incidence of cancer in a large cohort | Q43954571 |
| | Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway | Q44259125 |
| | Prospective study of serum cholesterol and site-specific cancers | Q44413704 |
| | Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study | Q45063452 |
| | Heart disease risk factors, diabetes, and prostatic cancer in an adult community. | Q45942773 |
| | Statin use and risk of prostate cancer in the California Men's Health Study cohort | Q46169918 |
| | Hypercholesterolemia and prostate cancer: a hospital-based case-control study | Q46428288 |
| | Hypertriglyceridemia as a possible risk factor for prostate cancer. | Q46699488 |
| | Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients | Q46710487 |
| | Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study | Q46897504 |
| | Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening. | Q51019661 |
| | Plasma cholesterol concentration and mortality. The Whitehall Study. | Q53796550 |
| P433 | issue | 11 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1545-1552 | |
| P577 | publication date | 2011-09-14 | |
| P1433 | published in | Cancer Causes & Control | Q325957 |
| P1476 | title | Serum total and HDL cholesterol and risk of prostate cancer | |
| P478 | volume | 22 | |